UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-02, Vol.41 (2), p.213-228

2018

Volltextzugriff (PDF)

Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care

American journal of health-system pharmacy, 2009-11, Vol.66 (22), p.2027-2031

2009

Volltextzugriff (PDF)

Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: An assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry

Clinical therapeutics, 2009-01, Vol.31, p.1478-1487

2009

Volltextzugriff (PDF)

Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population

Pharmacotherapy, 2018-04, Vol.38 (4), p.436-443

2018

Volltextzugriff (PDF)

Economic Implications of Sleep Disorders

PharmacoEconomics, 2010-11, Vol.28 (11), p.1015-1023

2010

Volltextzugriff (PDF)

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Clinical drug investigation, 2017-08, Vol.37 (8), p.763-773

2017

Volltextzugriff (PDF)

Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?

Expert opinion on drug safety, 2018-05, Vol.17 (5), p.519-523

2018

Volltextzugriff (PDF)

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-06, Vol.41 (6), p.643-644

2018

Volltextzugriff (PDF)

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

PharmacoEconomics, 2014, Vol.32 (1), p.5-13

2014

Volltextzugriff (PDF)

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018-02, Vol.18 (1), p.65-71

2018

Volltextzugriff (PDF)

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

International clinical psychopharmacology, 2008-03, Vol.23 (2), p.106-109

2008

Volltextzugriff (PDF)

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Clinical drug investigation, 2012-02, Vol.32 (2), p.139-144

2012

Volltextzugriff (PDF)

Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United States

Current therapeutic research, 2009-12, Vol.70 (6), p.472-476

2009

Volltextzugriff (PDF)

Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants

CNS drugs, 2002, Vol.16 (2), p.129-137

2002

Volltextzugriff (PDF)

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992–1997

Clinical therapeutics, 2000-12, Vol.22 (12), p.1575-1589

2000

Volltextzugriff (PDF)

Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010-01, Vol.10 (2), p.105-108

2010

Volltextzugriff (PDF)

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99

International clinical psychopharmacology, 2004-01, Vol.19 (1), p.17-22

2004

Volltextzugriff (PDF)

Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: An assessment of office-based visits 1990 to 1998

CNS drugs, 2000-12, Vol.14 (6), p.473-481

2000

Volltextzugriff (PDF)

Pharmaceutical economics & health policy

Clinical therapeutics, 1999-02, Vol.21 (2), p.382-382

Sclar, David Alexander

1999

Volltextzugriff (PDF)

Noncompliance with antihypertensive therapy. Economic consequences

PharmacoEconomics, 1996-01, Vol.9 (1), p.1-4

1996

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1998-11, Vol.20 (6), p.1192-1193

Sclar, David Alexander

1998

Volltextzugriff (PDF)

Treatment of depressive illness among children and adolescents in the United States

Current therapeutic research, 2000, Vol.61 (10), p.692-705

2000

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1998, Vol.20 (1), p.158-159

Sclar, David Alexander

1998

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1997-09, Vol.19 (5), p.1068-1069

Sclar, David Alexander

1997

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1997-07, Vol.19 (4), p.760-761

Sclar, David Alexander

1997

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(57)
Science & Technology
(57)
Humans
(26)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Pharmacology. Drug Treatments
(21)
Female
(17)
Male
(17)
Adult
(15)
Middle Aged
(14)
Psychology. Psychoanalysis. Psychiatry
(11)
Medicine
(10)
Medicine & Public Health
(10)
Medicine, Research & Experimental
(10)
Research & Experimental Medicine
(10)
Aged
(9)
Adolescent
(8)
Depression
(8)
Neuropharmacology
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care

Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: An assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry

Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population

Economic Implications of Sleep Disorders

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United States

Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992–1997

Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99

Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: An assessment of office-based visits 1990 to 1998

Pharmaceutical economics & health policy

Noncompliance with antihypertensive therapy. Economic consequences

Pharmaceutical economics & health policy: Editorial comment

Treatment of depressive illness among children and adolescents in the United States

Pharmaceutical economics & health policy: Editorial comment

Pharmaceutical economics & health policy: Editorial comment

Pharmaceutical economics & health policy: Editorial comment

Aktive Filter

Suchergebnisse filtern